FDA Inspection
Main Line Fertility CenterMain Line Fertility Center – FDA Inspection, Jun 30, 2022
Record Details
This FDA Inspection record concerns Main Line Fertility Center, with an inspection on June 30, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Main Line Fertility Center
- Inspection Date
- June 30, 2022
- Product Type
- Biologics
View Company Profile
ID · c54a63ea-664f-432e-a233-8d8c305a317e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1174847
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Main Line Fertility Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 11, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 1, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 16, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 10, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Main Line Fertility Center
- FDA Inspection 1245370 - 2024-06-27
- FDA Inspection 1092554 - 2019-06-11
- FDA Inspection 1017826 - 2017-06-01
- FDA Inspection 930635 - 2015-06-16
- FDA Inspection 840258 - 2013-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.